Broughton shares the highlights from RDD 2022
May 6, 2022
Broughton's Toxicology Managing Consultant Dr. Tony Jones summarizes the highlights and key takeaway messages from the Respiratory Drug ...
Pharmacovigilance - Artificial Intelligence and ...
March 8, 2022
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Technical Sales Administrator, Curtis Gallagher share thoughts on emerging topics ...
Consultation on Proposals for the Future of UK ...
March 2, 2022
Broughton's Head of Regulatory Affairs, Lloyd Smart, has recently published an article with the leading sector publication, PharmTech.
Broughton announces new US subsidiary and next ...
February 28, 2022
Broughton is establishing a U.S. subsidiary to enhance its presence in the region.
Broughton collaborates with leading global ...
December 7, 2021
Broughton's Director of Product Development Services, Dr Fozia Saleem, and Technical Sales Administrator, Curtis Gallagher collaborates ...
Joining the global pharmaceutical industry at CPhI
November 9, 2021
Broughton's Chief Scientific Officer, Chris Allen, and Technical Sales Administrator, Curtis Gallagher join with leading global ...
Innovate to accelerate. Blue-sky thinking hub.
March 30, 2021
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary announces the launch of our Blue-sky thinking hub aimed at nicotine, pharmaceutical, ...
